Potential influence of viral infection and vaccination on drug disposition.
D000818:Animals; D000914:Antibodies, Viral / Q000502:physiology; D000917:Antibody Formation; D002415:Cats; D002417:Cattle; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D004285:Dogs; D006207:Half-Life; D007369:Interferon Inducers; D007372:Interferons / Q000096:biosynthesis* / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism; D051379:Mice; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011817:Rabbits; D012087:Reoviridae / Q000502:physiology; D013806:Theophylline / Q000378:metabolism; D014611:Vaccination / Q000009:adverse effects / Q000662:veterinary*; D014613:Vaccines, Attenuated; D014777:Virus Diseases / Q000378:metabolism / Q000517:prevention & control / Q000662:veterinary*; D018406:Virus Physiological Phenomena
D000914:Antibodies, Viral; D007369:Interferon Inducers; D004364:Pharmaceutical Preparations; D014613:Vaccines, Attenuated; D007372:Interferons; D003577:Cytochrome P-450 Enzyme System; D013806:Theophylline